Google DeepMind, Meta, Isomorphic Labs Invest $300 Million in Biohub's Initiative to Build AI Data to Treat Disease
MT newswire2026/10/07 14:2010:20 AM EDT, 10/07/2026 (MT Newswires) -- Alphabet's (GOOGL, GOOG) Google DeepMind, Meta (META), and Isomorphic Labs are collectively investing $300 million in Biohub's Virtual Biology Initiative to build datasets for artificial intelligence models to predict and treat disease, Biohub said Wednesday. The investments will be used to create technologies and multi-modal datasets to enable the global scientific community to build and use AI models, allowing researchers to ask, predict, and answer biological questions digitally, Biohub said. Biohub added that the US Department of Energy will invest more than $500 million over five years in lab measurement, modeling and computation towards the initiative. Additionally, the US National Institutes of Health will coordinate the contribution of relevant datasets, repositories, and knowledge bases developed through over $500 million in prior similar federal initiatives, Biohub said. Price: 344.62, Change: -3.06, Percent Change: -0.88
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential
Goldman Sachs strategists have lowered their 12-month target for South Korea's KOSPI Index from 12,000 points to 9,000 points, representing a 25% decrease. Earlier this year, Goldman had raised the target multiple times. The latest downgrade is due to mounting concerns in the market over artificial intelligence (AI) trading.

AI investment has not ended; wealth is simply being redistributed.


Can NEAR Protocol defend $4.30 support after a 10% price drop?